<?xml version="1.0" encoding="UTF-8"?>
<p id="par0240">Different treatment approaches, including convalescent plasma, are currently being in use based on prior experiences with respiratory viruses since there is no specific therapeutic agent or vaccine for COVID-19 infection. In scope of the COVID-19 outbreak spread to Turkey, convalescent plasma therapy has been included into the treatment protocols of COVID-19 infection in the country as well as in many other countries (17 - 19). In this context, a “Guide on Supply and Clinical Use of COVID-19 Immune (Convalescent) Plasma” has been prepared and published in Turkey in order to standardize the collection, preparation, and use of CCP and to monitor all the processes including the follow-up of the patients those are treated with CCP.</p>
